Literature DB >> 1356123

Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.

C Cerdan1, Y Martin, M Courcoul, H Brailly, C Mawas, F Birg, D Olive.   

Abstract

The T cell adhesion molecule CD28 provides a costimulatory signal in combination with CD2 and CD3 mAb. CD28 regulates the expression of cytokines by T cells, not only IL-2, but also IL-1 alpha and CSF-1, usually synthesized by accessory cells. We have investigated the mechanisms through which CD28 modulates the expression of the IL-2R alpha chain. Whereas activation through CD2 or CD28 alone induced no or only low IL-2R alpha chain expression, activation through CD2 plus CD28 led to both a high and prolonged (greater than 14 days) cell surface and mRNA expression. In contrast, immobilized CD3 mAb-dependent activation induced a transient expression of the IL-2R alpha chain, which was neither further increased nor prolonged by CD28 costimulation. Upon CD2 plus CD28 stimulation, the half-lives of the two IL-2R alpha transcripts increased progressively between days 1 and 4, in contrast to each pathway alone. Whereas each activation pathway alone induced either no (CD2) or low (CD28) levels of IL-2R alpha gene transcription, the CD2 plus CD28 stimulation was associated with its increased transcription, which persisted at similar rates between 5 and 96 h post stimulation. The in vitro costimulation via the CD2 and CD28 molecules thus regulates the expression of the IL-2R alpha gene both at the transcriptional and post transcriptional levels. Our results therefore demonstrate a new immunoregulatory function of the CD28 molecule on IL-2R alpha expression, which, through its increased transcription rate and stabilization, could, together with high levels of cytokines secretion, be responsible for the prolonged T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356123

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Expression of both B7-1 and CD28 contributes to the IL-2 responsiveness of CTLL-2 cells.

Authors:  R Belani; G J Weiner
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus.

Authors:  J H Yeh; P Lecine; J A Nunes; S Spicuglia; P Ferrier; D Olive; J Imbert
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

4.  Transcriptional repression of specific host genes by the mycovirus Cryphonectria hypovirus 1.

Authors:  P Kazmierczak; P Pfeiffer; L Zhang; N K Van Alfen
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Activation of bovine lymphocyte subpopulations by staphylococcal enterotoxin C.

Authors:  W A Ferens; W C Davis; M J Hamilton; Y H Park; C F Deobald; L Fox; G Bohach
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.

Authors:  R G Bryan; Y Li; J H Lai; M Van; N R Rice; R R Rich; T H Tan
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 7.  The role of the T cell in autoimmune inflammation.

Authors:  Alla Skapenko; Jan Leipe; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

8.  Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity.

Authors:  J Nunes; S Klasen; M D Franco; C Lipcey; C Mawas; M Bagnasco; D Olive
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

9.  Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes.

Authors:  D Bevec; H Klier; W Holter; E Tschachler; P Valent; F Lottspeich; T Baumruker; J Hauber
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis.

Authors:  Roman Tatura; Michael Zeschnigk; Wiebke Hansen; Joerg Steinmann; Pedrina Goncalves Vidigal; Marina Hutzler; Eva Pastille; Astrid M Westendorf; Jan Buer; Jan Kehrmann
Journal:  Immunology       Date:  2015-07-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.